Synopsis of recent research by authors named "Anat Lowenstein"
- Anat Lowenstein's recent research primarily focuses on the development and standardization of imaging biomarkers, particularly through Optical Coherence Tomography Angiography (OCT-A), for the evaluation and management of diabetic retinal disease (DRD), emphasizing the need for consistent terminology and grading methods to improve clinical interpretations.
- The author addresses the challenges associated with non-neovascular age-related macular degeneration (AMD), highlighting the lack of effective treatments for this form of the disease while providing insights into its pathogenesis and ongoing research into potential therapies.
- Lowenstein's work also discusses the advent of ophthalmic biosimilars, particularly in relation to anti-VEGF treatments for retinal diseases, as well as the implications of patent expirations on the market, suggesting significant changes on the horizon for retinal disease management.
